XNK Therapeutics

XNK Therapeutics AB is an immunotherapy company dedicated to preventing and treating cancer by developing novel therapies based on NK cells. The company's platform technology and leading research autologous candidate drug, CellProtect, possess ideal properties for targeting cancer, including applications where allogeneic cell products are not suitable. This product will become a key component of future cancer treatment strategies.